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Introduction: High levels of physical, cognitive, and psychosocial impairments are
anticipated for those recovering from the COVID-19. In the UK, ∼50% of survivors
will require additional rehabilitation. Despite this, there is currently no evidence-based
guideline available in England and Wales that addresses the identification, timing and
nature of effective interventions to manage the morbidity associated following COVID-19.
It is now timely to accelerate the development and evaluation of a rehabilitation service to
support patients and healthcare services. Nuffield Health have responded by configuring
a scalable rehabilitation pathway addressing the immediate requirements for those
recovering from COVID-19 in the community.
Methods and Analysis: This long-term evaluation will examine the effectiveness
of a 12-week community rehabilitation programme for COVID-19 patients who have
been discharged following in-patient treatment. Consisting of two distinct 6-week
phases; Phase 1 is an entirely remote service, delivered via digital applications.
Phase 2 sees the same patients transition into a gym-based setting for supervised
group-based rehabilitation. Trained rehabilitation specialists will coach patients across
areas such as goal setting, exercise prescription, symptom management and emotional
well-being. Outcomes will be collected at 0, 6, and 12 weeks and at 6- and
12-months. Primary outcome measures will assess changes in health-related quality
of life (HR-QOL) and COVID-19 symptoms using EuroQol Five Dimension Five Level
Version (EQ-5D-5L) and Dyspnea-12, respectively. Secondary outcome measures
of the Duke Activity Status Questionnaire (DASI), 30 s sit to stand test, General
Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-9 (PHQ-9), Patient Experience
Questionnaire (PEQ) and Quality Adjusted Life Years (QALY) will allow for the evaluation of
outcomes, mediators and moderators of outcome, and cost-effectiveness of treatment.
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Discussion: This evaluation will investigate the immediate and long-term impact, as well
as the cost effectiveness of a blended rehabilitation programme for COVID-19 survivors.
This evaluation will provide a founding contribution to the literature, evaluating one of the
first programmes of this type in the UK. The evaluation has international relevance, with
the potential to show how a new model of service provision can support health services
in the wake of COVID-19.
Trial Registration: Current Trials ISRCTN ISRCTN14707226
Web: http://www.isrctn.com/ISRCTN14707226
Keywords: COVID-19, rehabilitation, exercise, emotional well-being, digital health, NHS, independent sector
INTRODUCTION
Clinical Impact of COVID-19
In late 2019 a highly pathogenic novel coronavirus (CoV),
severe acute respiratory syndrome (SARS)-CoV-2, emerged,
causing a global pandemic with millions of cases worldwide
(1). SARS-CoV-2 commonly attacks the respiratory system,
leading to hospitalisation with many requiring breathing support
advancing in some cases to intensive care support (2). Further
complications include those meeting diagnostic criteria for acute
respiratory distress syndrome (ARDS), anaemia, cardiac injury
and secondary infection (2). COVID-19 is a highly infectious
respiratory disease and as a result the COVID-19 pandemic
has profoundly impacted the UK population resulting in strict
measures to curtail the spread of infection. This disease was
unknown in humans and most research has concentrated on
the acute phase to reduce mortality. Acute treatment is largely
symptomatic and supportive depending on the severity of
infection. As of June 2020, there was no specific treatment or
vaccination available. Indications show that COVID-19 will have
a profound long-term impact on those infected as was previously
seen following the MERS and SARS pandemics. MERS survivors
showed significantly negatively impacted HR-QoL for up to 14
months post-virus (3) indicating that rehabilitation should be
measured in months/years rather than weeks (4).
Data from previous pandemics such as those described,
indicates a number of adverse side effects in recovering patients.
Long-term ventilatory dysfunction and associated lung damage
are common characteristic as are muscle weakness and fatigue
(5, 6). Whilst less common, metabolic disorders, including
hyperinsulinemia, insulin resistance, hyperglycemia, and type 1
or 2 diabetes were reported in recovering SARS patients (4).
Non-physical morbidity such as psychological morbidity and
cognitive dysfunction are also common after a period of critical
Abbreviations: ARDS, Acute respiratory distress syndrome; AUC, Area under
the curve; CIMSPA, The Chartered Institute for the Management of Sport and
Physical Activity; CK, Creatine kinase; COVID-19, Corona virus disease; CPD,
Continued professional development; EQ-5D-5L, EuroQoL Five Dimension Five
Level Version; GAD-7, General anxiety disorder assessment-7; H7N9, Avian
influenza; HR-QoL, Health Related Quality of Life; ICU, Intensive care unit;
IL-6, Interleukin-6; MERS, Middle East respiratory syndrome; NHS, National
Health Service; PEQ, Patient experience questionnaire; PHQ-9, Patient health
questionnaire-9; PTSD, Post-traumatic stress syndrome; QALY, Quality adjusted
life years; SARS, Severe acute respiratory syndrome.
illness such as COVID-19. It has been reported that 1 in
10 critically ill patients develop severe psychological problems
including anxiety, depression and post-traumatic stress disorder
(PTSD) (7). Whilst there are a multitude on contributory
mechanisms, the potential areas of comorbidity here all represent
important target areas within rehabilitation.
It is anticipated that COVID-19 will hospitalise ∼150,000
people by the end of 2020. Of those individuals, it is suggested
that 50% will require additional rehabilitation support in the
community to support improvement in HR-QoL (8) and to
reduce burden on NHS services.
Impact on Rehabilitation Services
The COVID-19 pandemic has acted as a sharp reminder as
to the exceptional work of the National Health Service (NHS).
As we move further through the pandemic patients are being
medically discharged in growing numbers. As patients move
out of the acute phase of care it is clear to see the impending
burden facing rehabilitation services, described by the Chartered
Society of Physiotherapy as an “tsunami of rehabilitation need”
(8). Normal health and social care delivery in many countries,
including the UK has been deferred in order to support the
acute phase of COVID-19. Healthcare interventions aimed at
improving or maintaining function such as falls prevention
programmes, as well as well-established rehabilitation pathways
such as cardiac and pulmonary rehabilitation, are unable to
continue, with potential deleterious effects on function. These
issues risk worsening health, physical and psychological function
for vast numbers of people who may not have suffered from
COVID-19 directly (9). As movement restrictions are lifted,
the consequences of these indirect effects of the pandemic will
become apparent. Prior to the COVID-19 pandemic, to meet
the 18-week standard for newly referred patients and clear the
backlog of patients who will have already waited longer than 18
weeks, the NHS would have needed to treat an additional 500,000
patients a year for the next 4 years. The pandemic is likely to
make waiting lists grow further and the challenge will be even
greater (10).
Alarmingly and as has been made clear by National
Institute for Health and Care Excellence (NICE) there is
currently no evidence-based guideline available in England and
Wales that addresses the identification, timing and nature of
effective interventions to manage the physical and non-physical
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morbidity associated following COVID-19 (11). Progress is
being made, with an initial framework devised for assessing
early rehabilitation needs of COVID-19 patients, following
intensive care treatment. Much more work is required to address
the spectrum of needs, particularly for those that have not
spent time in intensive care (12). Pulmonary rehabilitation
has been shown to be successful in improving exercise
tolerance and HR-QoL, and has been shown to reduce hospital
admissions rates in patients with COPD (13, 14), yet despite
the associated severe muscle wastage and deconditioning, on-
going dyspnoea, sleep disorders and severe fatigue, memory
problems, anxiety, depression, and post-traumatic stress disorder
(15), rehabilitation is neither defined or guaranteed for those
recovering from COVID-19.
New Models of Rehabilitation
A rapid expansion in rehabilitation services is necessary to
support an increasing number of patients suffering from long-
term complications of COVID-19. Given the level of urgency,
a more diverse rehabilitation workforce is required to meet the
scale of this challenge, using capacity and skills from sectors
outside healthcare organisations. Specifically, improved capacity
could be achieved by developing rehabilitation capabilities across
the wider non-registered health care staff, including specialist
trained exercise professionals, to help meet both demand and
effective dose and progression of exercise (16).
The Australian healthcare system may provide a strong basis
upon which to base a new model of rehabilitation support,
utilising the expertise of exercise professionals. Inclusion of
exercise professionals within the Australian healthcare sector has
resulted in substantial healthcare cost savings with annual well-
being gains of $7,967 and $11,847 per person with diabetes and
cardiovascular disease, respectively, with a benefit-cost ratio of
9:1 and 6:1 (17).
Compelling data also exist for the cost effectiveness of exercise
in the treatment of mental health, dementia and other common
chronic diseases (17) The utilisation of exercise professionals
to support clinical rehabilitation is something that has been
long employed by Nuffield Health, rendering the Charity well-
placed to mobilise and investigate the approach with a cohort
of COVID-19 survivors. It should be made clear, that at
present there is no formal accreditation pathway for clinical
exercise physiologists.
Not only is the organisation of personnel key to new models
of rehabilitation, but also the mode of delivery. Delivery modality
of rehabilitation will be one of the most significant changes as
we progress through the Post-COVID-19 phase. To reduce the
number of “face to face” consultations and indeed resource strain,
remote consultations including telephone and video platforms
have evolved significantly to provide a continuity of care (18).
Whilst previous uptake of digital rehabilitation options has been
poor (19) this delivery approach has been shown to confer
positive health and well-being outcomes in participants that
showed strong adherence (19–21). As an example, “Activate
Your Heart” is a well-established digital cardiac rehabilitation
programme and was evaluated in several different locations.
Data demonstrated that users’ exercise capacity and HR-QoL
improved after completing the programme (22).
The restrictive conditions associated with the COVID-19
lockdown and indeed social anxieties as restrictions are lifted,
suggest that there will likely be a greater acceptance of digital
healthcare from both a patient and clinician perspective (23,
24). Nuffield health has experience in delivering remote digital
interventions for mental health, primary care and physiotherapy.
The learnings from these areas will be built into the development
of the remote COVID-19 rehabilitation programme. The digital
component will be evaluated for both clinical effectiveness as well
as acceptability from both the clinician and patient perspective.
Aims
The aim of the present evaluation is to implement and appraise
a novel model of community rehabilitation for individuals
recovering from COVID-19. The focus will be on the clinical
effectiveness of the programme for improvements in HR-QoL
and suppression of COVID-19 related symptoms. The specific
research questions include the following:
• Is HR-QoL improved and are symptoms related to COVID-19
reduced at 6 and 12 weeks post-intervention and are benefits
retained at 6 and 12 months?
• Is a novel blended model (digital and physical) of care
cost-effective in the rehabilitation of those recovering
from COVID-19?
• Is a novel blended rehabilitation programme acceptable to
both patients and rehabilitation specialists?
We hypothesise that: (a) the 12-week rehabilitation programme
will be effective in improving HR-QoL and reducing symptoms
related to COVID-19 at 6 and 12 weeks and those benefits
will be retained at 6 and 12 months; (b) the blended
model will be cost effective when compared to previously
described rehabilitation methodologies, specifically outpatient
multidisciplinary pulmonary rehabilitation; (c) we expect the
programme to be acceptable to both patients and specialists.
METHODS AND ANALYSIS
Trial Design
The protocol presented herein reflects Protocol Number 01. Any
amends to this protocol will be detailed in full within the ISRCTN
registry. This observational cohort study will be conducted
following the STROBE statement (25) for observational studies
with the protocol reported in line with SPIRIT Statement
(26). We will examine the effectiveness of a 12-week blended
community rehabilitation programme on improvements in HR-
QoL and reductions in symptoms of COVID-19, in individuals
recovering from the disease.
This evaluation will be conducted in concert with the
NHS. Initially the programme will be deployed across 4 NHS
locations, namely; University Hospitals of North Midlands
Trust, Newcastle upon Tyne Hospitals NHS Foundation
Trust; Birmingham and Solihull Community Care Group and
Central Manchester University Hospitals Trust. Whilst these
locations are clustered in the North and Midlands they are
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TABLE 1 | Inclusion and exclusion criteria.
Inclusion criteria Exclusion criteria
Previous diagnosis of COVID-19 Active COVID-19 symptoms
Able to walk independently for a
minimum of 20m
Are already receiving community
rehabilitation




Have un-managed medical conditions
that contraindicate unsupervised
exercise
18 years of age and over Have a formal diagnosis of
post-traumatic stress syndrome,
clinically significant anxiety or
depression where low intensity mental
health intervention will not assist
Access to transport for phase 2
attendance
Have been diagnosed with Chronic
Fatigue Syndrome
demographically and economically diverse. The NHS sites will
be serviced by 8 surrounding Nuffield Health Fitness and Well-
being Centres, all of which are registered with the Care Quality
Commission and are located within a 20-mile radius of a
participating NHS site. Each trust will be assigned 2 rehabilitation
specialists from Nuffield Health to support the programme. As
this intervention will be offered as a National service, recruitment
is open ended beginning in September 2020. Nuffield Health
intend to expand provision by operationalising all 112 of its
fitness and well-being centres in 2021. These locations cover all
7 geographical regions as defined by NHS criteria. An initial
evaluation cohort will not exceed 160 participants ensuring that
a participant practitioner ratio of 1:10 is not exceeded.
Those wishing to access the programme can do so via NHS
referral, this can be through doctor, nurse or other allied health
professional such as a physiotherapist. Patients will only be
referred if they meet the qualifying criteria presented in Table 1.
Once referred, the patient will complete an online
pre-assessment health questionnaire. Once completed the
questionnaire is made available digitally to a specialist trained
physiotherapist who will contact the patient to conduct a
telephone triage assessment. Following successful triage, the
patient is handed on to a rehabilitation specialist who then takes
up responsibility of the patients care. All patients will receive the
identical 12-week programme structure consisting of two 6-week
phases, depicted in Figure 1 and described in detail below.
Rehabilitation Programme
1. NHS healthcare professionals will utilise inclusion/exclusion
criteria at the point of discharge to refer a patient to the
programme. Alongside the provision of a patient information
document, the patient will be fully informed verbally about
the programme, being given the opportunity to join the
programme should they so wish. The patient will be made
aware that their data will be utilised anonymously for research
purposes. The patient may also request that their data is not
utilised and will still be able to participate in the programme.
Should they choose not to progress they will be sign-posted
to alternative community/NHS services where available. If the
patient accepts to progress on to the programme the NHS
healthcare professional will complete an online referral, sent
directly to Nuffield Health using a secure online form. Data
sharing agreements have been completed between NHS and
Nuffield Health and all processes conform to GDPR and NHS
digital requirements.
2. When an online referral is completed, an automated booking
process is triggered. Via email or telephone (based on patient
preference) the patient will choose an appointment time for
an initial triage screening. The patient will also be asked to
complete pre-screening questions, designed to support the
triage process.
3. The patient next joins a telephone or online video triage
consultation utilising this feature. The triage is conducted by
specialist physiotherapists trained in remote consultation. The
triage is designed to be an additional safety step ensuring
that the patient is clinically fit to progress onto the 12-
week programme. The 45-min triage will also act to collect
additional relevant patient information that may be pertinent
when tailoring their exercise programme. Information such as
details on additional co-morbidities, emotional well-being and
medication will be discussed. Should any contraindications
to exercise be identified during the triage the patient will be
informed that they are unable to progress on the programme
at that time. The patient will be sign-posted back to their
General Practitioner, who will also be notified in writing. The
original referring clinician will also be notified. At the end
of triage, if deemed appropriate, the specialist physiotherapist
will refer the patient to the rehabilitation specialist with
recommendations for the intensity of entry level exercise and
specific needs and goals.
4. Following successful triage, the patient will be automatically
sent a welcome pack via post as well as email. This will provide
full guidance on how to download, access and register on the
digital platforms and will provide links to learning materials.
The patients GP will also be made aware that their patient
has initiated the programme. The digital application platform
utilises the functionality of a platform already used extensively
across Nuffield Health (MyTherapy, Nuffield Health, London,
UK). All other virtual audio-visual communication will be
delivered by a separate digital system (Microsoft Teams,
Microsoft, Redmond, USA).
5. Within 72 h of referral, the patient will be contacted by their
assigned rehabilitation specialist based at a Nuffield Health
site within a 20-mile proximity to the referring hospital.
practitioner will provide a welcome to the programme, offer
the opportunity to ask any questions and to inform them of
the start date of the programme.
6. The patient begins the 12-week programme. This programme
phases are as follows:
Phase 1
Weeks 1–6 will consist of 3 exercise sessions per week. Session
1 will be an online live streamed activity conducted by 2 Nuffield
Health trained rehabilitation specialists. One practitioner will run
the exercise session and the second will answer questions via the
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FIGURE 1 | Pathway illustration of the 12-week community rehabilitation programme.
online chat function. The stream will be a 1-way stream, meaning
that whilst multiple patients will access the stream at any given
time, they will not be recorded/filmed nor will their personal
details be visible to the group. A maximum of 10 patients will
join a stream at any time. The live stream will last up to 45-min
followed by a 15-min period for questions via the secure online
chat function or alternatively spoken questions can be provided
should the patient have microphone functionality.
The second session of the week during phase 1 will be self-
directed. The patient will be directed to a pre-recorded guided
exercise session located on a dedicated online platform (Vimeo,
New York, USA). This will be a 45-min activity which the patient
completes at their leisure. All exercises are designed such that
they can be carried out with ease at home.
The third exercise session of the week is described as “build
your own.” The patient’s workbook provides the patient a menu
of activities suitable for them, which they may select to populate
an exercise session commensurate with their personal threshold.
Each week the patient will be provided a phone call that
will last up to 45-min with the rehabilitation specialist. The
aim of the phone call is to listen to any patient queries
but to also offer support on themes such exercise selection,
symptom management and emotional well-being. Nuffield
Health specialists have comprehensive training in each of these
areas. Prior to progressing to Phase 2 patients will receive a
remote mid-point review by the rehabilitation specialist. Progress
will be discussed in detail and the patient will be asked if
they feel ready and willing to progress to phase 2. If their
progress is deemed insufficient, the patient will be recommended
to complete another 6-week digital programme in full, before
moving into a gym-based setting. Progress will be reviewed
weekly and patients will be able to join the face to face component
at a later point. All group-based sessions will be offered at two
time points across the course of the day, with an AM and PM
option. All one to one activity such as the weekly phone calls will
be booked according to participant preference on a weekly basis.
All above processes intended to maximise participant retention
throughout the course of the evaluation.
Phase 2
Following successful completion of phase 1, patients will progress
to the phase 2 face to face programme. This phase will be
conducted in strictly controlled gym environments conforming
to all necessary Government and Public Health England (PHE)
guidance. As per phase 1, phase 2 will consist of 3 exercise
sessions per week. The first session of the week will be a
rehabilitation specialist lead group exercise programme. In
appropriately prepared and ventilated spaces, groups of up to
5–10 patients will engage in a 45-min exercise class followed
by 15min for questions and answers. Exercises will consist of
aerobic and strength-based exercises as well as stability and
mobility. In order to promote continued self-management, the
second exercise session of the week will be a remote pre-recorded
session that the patient will carry out at home independently,
as per phase 1. Similarly, the third session of the week, “build
your own” will remain; however, the patient will be encouraged
to complete this session within a supervised gym environment.
The rehabilitation specialist will be on hand within pre-defined
time slots to provide advice and guidance. The patient will again
receive a weekly consultation with the rehabilitation specialist
following the aforementioned themes. This will culminate
between weeks 12 and 13 with a final assessment, summary report
and sign-posting to additional services where required.
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Practitioner Recruitment and Training
Rehabilitation specialists will be recruited and trained from a
pool of exercise professionals working within Nuffield Health. All
exercise professionals have a foundation training to a minimum
of The Level 3 Personal TrainingQualification from an accredited
training provider, with preference for professionals trained to
level 4. The competencies associated with these qualifications can
be found elsewhere. All professionals are registered with The
Chartered Institute for the Management of Sport and Physical
Activity (CIMSPA). As part of this registration, all professionals
are required to engage in continued professional development
(CPD) as part of their contract of employment, with a pre-
requisite to attain a minimum of 10 CPD points each year. Given
the unique structure of Nuffield Health, all exercise professionals
have experience working with clinical populations and work
closely with clinical professionals on a daily basis within a shared
learning environment.
Utilising the Nuffield Health accredited training academy,
a multi-disciplinary team of clinical and exercise experts as
well as experienced clinical operations specialists will deliver
a comprehensive programme of training to up skill exercise
professionals to COVID-19 rehabilitation specialists. At present
no external standards exist regarding specific competencies
in this area. The design of the programme and its content
has however been carried out in collaboration with NHS
representatives and key authorities from organisations leading
rehabilitation nationally.
Training will be delivered via a blended learning approach
utilising a mixture of interactive virtual classrooms, online
learning, webinars and question and answer sessions. The
content to be included covers:
• An overview of the clinical impact of COVID-19, long term
effects and the requirement for community rehabilitation and
its goals.
• Roles and responsibilities of those involved in delivery of the
rehabilitation programme.
• Physiotherapists will be refreshed on initial subjective
assessment, screening for inclusion/exclusion and need for
onward referral, use of outcome measures and handover
process to ensure seamless patient journey.
• Exercise professionals cover week by week roles and
responsibilities, systems training, outcome measures, red flags
and escalation processes.
• Exercise professionals will further refresh and advance
coaching skills, exercise programming, great conversations
skills, exercise progression, and regression.
• All will receive mental Health First Aid training—recognising
signs and symptoms of emotional distress and understanding
how to signpost to appropriate treatment pathway.
All training will be assessed via formal assessment testing
theoretical knowledge via online examination and practical skills
assessed via role play scenarios and “course-work” tasks.
Patient and Public Involvement
Patients were first involved in this evaluation at their point of
clinical referral following a 12-week post discharge follow up.
The research questions posed within the protocol paper were
constructed with the support of NHS clinicians whom work
directly with this clinical population as well-members of NHS
Trust management. We believe that the research questions reflect
the immediate and on-going needs of the NHS who have a strong
insight as to their patient’s needs.
Qualitative feedback will be collected from patients
throughout their rehabilitation. An initial cohort of 100 patients
will be invited to review each milestone of the programme as part
of a focus group following their rehabilitation. An evaluation
period will then be employed to refine the pathway based on
patient feedback, this will include feedback on outcome and
recruitment methods.
A patient survey will be provided to all participants that
were eligible for the rehabilitation programme gauging views on
the dissemination plan and how the intervention may further
integrate into community settings.
MEASURES
Outcome data will be collected at 0, 6, and 12 weeks and again
at 6- and 12-months post-intervention. Self-report data will be
collected via digital application (MyWellbeing, Nuffield Health,
London, UK). The patient will be emailed and provided a push-
notification prompting them to complete the aforementioned
questionnaires. Whilst this evaluation will not utilise any formal
comparison group, it is intended that collaboration with trusts
will support the analysis of anonymised “usual care” outcome
data. This is likely to come from community physiotherapy
and/or modified pulmonary rehabilitation.
All data will be securely stored on a dedicated Nuffield
Health server and will be retained in line with the organisations
publicly available data retention schedule. Modifications to
data written to the database will be documented through via
an internal inquiry system. Data entered into the database
will be retrievable for viewing throughout by those granted
secure access privileges associated with an identification
code and password. Any data errors will be summarised
along with detailed descriptions for each specific problem
in a data query reports, which will be sent to the study
Outcomes Analyst. The Outcomes Analyst will check
any inconsistency, checking other sources to determine
required corrections. Any coding changes required within
the digital data capture system will then be implemented
within 24 h.
Complete back up of the primary database will be performed
twice a month. Incremental data back-ups will be performed
on a daily basis. In addition to system back-ups, additional
measures will be taken to back-up and export the database on
a regular basis at site level. The outcomes analyst will send
weekly email reports with information on missing data, missing
forms, and missing visits to site level co-ordinators who will
then rectify immediately as and when required. Data security
audits will be completed by the Nuffield Health Information
Security group on a quarterly basis. Full details of group
membership and details of audit processes can be provided
upon request.
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Primary Outcome Measures
EuroQoL Five Dimension Five Level Version
(EQ-5D-5 L)
This measure is used to assess a person’s perception of their
general health state and obtain a measure of quality adjusted
life years (QALYs). Outcomes can be benchmarked against UK
population norms. It covers five dimensions: mobility, self-
care, usual activity, pain/discomfort and anxiety/depression,
which are rated by the person on five levels of severity:
no problems, slight problems, moderate problems, severe
problems and extreme problems/unable to function within that
domain (27).
Dyspnea-12
Dyspnea-12 consists of 12 descriptor items on a scale of none
(0), mild (1), moderate (2), or severe (3). It provides an
overall score for breathlessness severity that incorporates seven
physical items and five affective items. The time reference period
for “these days” captures the current level of breathlessness
experienced by patients as opposed to specifically on the day
of the test or in response to a specific activity. Total scores
range from 0 to 36, with higher scores corresponding to greater
severity (28).
Secondary Outcome Measures
Duke Activity Status Index
The Duke Activity Status Index (DASI) is an assessment
tool used to evaluate the functional capacity of patients with
cardio-pulmonary diseases (29). The activities in the scale are
chosen to represent major aspects of physical function, i.e.,
personal care, ambulation, household tasks, sexual function, and
recreational activities. As such, these responses can also be used
to assess physical limitations relevant to the patient’s HR-QoL.
Responses from 12 items are summed up to get a total score,
which ranges from 0 to 58.2. Higher scores indicate a higher
functional capacity.
30 s Sit to Stand Test
The 30 s Sit to Stand Test is utilised for testing strength and
endurance in a variety of cohorts. It is part of the Fullerton
Functional Fitness Test Battery (30). This test was developed to
overcome the floor effect of the 5 or 10 repetition sit to stand
test in older adults. The 30-s chair stand involves recording the
number of stands a person can complete in 30 s rather than the
amount of time it takes to complete a pre-determined number
of repetitions. That way, it is possible to assess a wide variety of
ability levels with scores ranging from 0 for those who cannot
complete 1 stand to > 20 for more fit individuals.
Generalised Anxiety Disorder-7
GAD-7 comprises 7 items measuring symptoms and severity
of anxiety based on the DSM-IV diagnostic criteria for GAD.
The GAD-7 has good internal consistency (α = 0.92) and
good convergent validity with other anxiety scales. Higher
scores indicate greater severity of symptoms. The GAD-7
has increasingly been used in large-scale studies as a generic
measure of change in anxiety symptomatology, using a cut-off
score of 8 (31).
Patient Health Questionnaire-9
The PHQ-9 is a self-report measure of depression that has been
widely used in research and is a regular screening measure
utilised in primary care and hospital settings. The PHQ-9
items reflect the diagnostic criteria for depression outlined by
the Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition—Text Revision (DSM–IV–TR) (32). Summary
scores range from 0 to 27, where larger scores reflect a greater
severity of depressive symptoms. The PHQ-9 has been found
to discriminate well between depressed and non-depressed
individuals using the cut-off total score≥10, with good sensitivity
(88.0%), specificity (88.0%) and reliability (33).
Patient Experience and Programme
Acceptability
The Patient Experience Questionnaire (PEQ) instrument will
be used to assess patient experience and satisfaction. The
PEQ contains several quantitative questions and open-ended
questions that are used to assess participant’s views and
satisfaction with service provision (34).
Costs
EQ-5D-5 L utilities will be reported alongside the full evaluation
costs of the intervention so as to elicit a “per head” economic
evaluation of all participants recruited (35).
Engagement and Usage Measures
The digital systems will collect anonymized descriptive data
relating to engagement and usage of the service users with the
platforms. Data collected will include the number of sessions
attended, time spent in the platform, number of activities
completed, number of minutes per log-in, number of resources
accessed. A session is defined as an instance where a user logs
on to the system. Session time will be always an imperfect
calculation, as users may take breaks within a session, without
formally log out of the system. To prevent this overestimation,
periods of more than 30min without interaction will be taken
as 1min and periods of inactivity longer than 3 h will start the
count on a new session. Use of different program components
will be measured.
Statistical Analysis
Participation levels will bemonitored throughout the programme
and reasons for withdrawal or non-compliance will be recorded.
All participants are selected according to clinical criteria alone
with no other factors influencing participation so as to limit
selection bias. Information biases are limited via the prospective
nature of this evaluation and the methodology employed to
collect mandatory data at each designated time point. As well as
the primary and secondary outcome measures being collected, a
detailed clinical history and additional triage will be undertaken
for each participant. This will limit confusion bias through
the identification of relevant confounding clinical variables.
Efficacy of treatments over time will be measured using mixed
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effects models. To complement the post-hoc comparisons, the
magnitude of change on the primary and secondary outcomes
measures will be established using Cohen’s d statistic. Bonferroni
corrected p-values will be reported for multiple comparisons.
Participants with missing data will be removed for analysis with
complete-case analysis being utilised.
An interim-analysis will be performed on the primary
endpoint when 50% of participants have completed up to the 6-
month follow up point. The interim analysis will be performed
by an independent statistician. The statistician will report to the
principal investigator (BMK) only. The principal investigator will
have unblinded access to all data and will discuss the results of the
interim analysis with the project team.
Ethics and Dissemination
ManchesterMetropolitanUniversity Ethics Committee approved
this study on 29/09/2020 (Ref: 25307). Informed consent will
be gained from all participants prior to referral onto the
rehabilitation programme. Consent will be captured digitally as
part of the online referral programme.
Participants will be contacted weekly to ensure that any
clinical concerns are addressed and escalated where relevant.
Processes are in place to inform the referring clinician and
the participants general practitioner should medical intervention
be required.
The principal investigators will have access to the cleaned data
sets. Project data sets will be housed securely within the project
database hosted on a secure Nuffield Health server. Should data
sharing be required under reasonable request (e.g., with the NHS)
a secure file transfer protocol will be created for the study, and all
data sets will be password protected. To ensure confidentiality,
data dispersed to project team members will be blinded of any
identifying participant information.
Pilot data is expected by December 2021 and will be published
in an open access journal. Any intellectual property pertaining
to successful delivery of the service will be shared directly with
NHS partners.
DISCUSSION
New models of rehabilitation are urgently required to address
the immediate gap in provision for those recovering from
COVID-19 as well as the escalating back log of rehabilitation
cases nationally. Nuffield Health, the UK’s largest not-for-profit
healthcare charity, have long prioritised exercise as a first line
intervention for the treatment and prevention of long-term
conditions. This has been successfully achieved via a uniquely
structured estate linking hospitals and health and well-being
centres as well as the up skilling of exercise professionals to work
with clinical populations. Now, by working closely with the NHS,
a unique learning partnership will assist in the development of
a new rehabilitation pathway, that may later evolve to utilise
the expertise of the fitness sector in supporting the NHS and
its rehabilitation needs. We must also later review in detail
how we create a model that has utility beyond the healthcare
system within the United Kingdom, such that patients are able to
benefit from this level of support internationally, within varying
healthcare structures.
Undertaking the principal aim of this trial will allow for
a robust test of the effectiveness of a new 12-week blended
rehabilitation programme within a population that has not
previously been investigated within a community rehabilitation
context. Specifically, this work will provide new insight into
changes in HR-QoL and disease specific symptoms related
to COVID-19 following 12-weeks of exercise rehabilitation.
Positive results of these main outcome measures will allow the
programme to consolidate itself as not only a valid treatment
option, but as an essential component to the care management
pathway of COVID-19 survivors, and indeed those recovering
from other serious conditions.
The novel structure of the programme will support further
expansion of digital components within the rehabilitation of
those recovering from serious illness. This is relevant not just for
improving access to information and efficiency of data collection
but critically, the remote delivery of care and the ability to
individualise programmes of rehabilitation. The relevance of the
results will likely have implications for the implementation and
success of blended rehabilitation models i.e., digital and physical
combined, across health care systems worldwide.
Examining potential mediators and moderators of change will
contribute to our understanding of key processes in achieving
improvement in services using blended models of rehabilitation.
Whilst mediators and moderators of rehabilitation outcomes
have been explored, this will be the first exploration of a
combined digital/physical intervention. This will inform the
tailoring of interventions to best address the needs of the targeted
population, ultimately leading to the development of more
effective interventions.
An area requiring on-going review and indeed development
relates to the provision and impact of rehabilitation across
sociodemographic groups. Black, low-income, and immigrant
communities are particularly vulnerable and disproportionately
impacted by COVID-19 (36, 37). Furthermore, data exists
indicating that secondary care-based clinics may be underused
by older populations and those in poorer socioeconomic
circumstances (37). The proposed evaluation will ensure that
sociodemographic variation is considered within analysis
and that a representative sample from those that are
disproportionately affected are consulted post-programme
to understand barriers and facilitators. It is critical that learnings
are continuous and that they are built into future re-iterations of
the rehabilitation programme.
The proposed economic analysis will add to the current
literature in regard to evidence of the cost-effectiveness of
home or web-based rehabilitation programmes and will be
an innovative analysis of a clinical rehabilitation programme
ran independently of allied health professionals within a non-
NHS community environment. In a context of health care
provision where resources are now especially stretched, cost-
effective interventions can only support the delivery of effective
health services.
In summary, COVID-19 has proven devastating in its cost of
life and long-term impact on survivors. Scalable interventions
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must be developed to address what will be a long-term
requirement in the rehabilitation of patients having suffered
critical illness. To achieve rapid scalability, blended interventions
will soon become a recognised viable option across health
care. They can be beneficial both in costs and resource
management within the NHS and will bring disparate sectors
closer together in a combined mission of improving the health
of the nation. It is critical that as technology rapidly develops,
supporting innovative models of care so too must research
in order to rapidly continually and rapidly update on the
benefits of providing blended community rehabilitation. This
long-term evaluation aspires to drive research and innovation
forward, and in doing so support the NHS in its aim of
controlling the impacts of COVID-19 and delivering on its long-
term plan.
SUMMARY
Strengths and Limitations of This Study
• Evaluates a critical and novel patient cohort.
• This evaluation will review the impact of digital and physical
approaches to rehabilitation.
• Evaluates a new model of care delivery and the training of
non-clinical staff.
• Demonstrates strong example of NHS/independent
sector collaboration.
• A significant proportion of data will be self-reported due to
COVID-19 restrictions.
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